Addus HomeCare (NASDAQ:ADUS) Receives “Overweight” Rating from Stephens

Addus HomeCare (NASDAQ:ADUS)‘s stock had its “overweight” rating reissued by investment analysts at Stephens in a report released on Wednesday,Benzinga reports. They presently have a $142.00 target price on the stock. Stephens’ target price suggests a potential upside of 52.06% from the stock’s current price.

Several other research analysts also recently issued reports on the company. Macquarie reaffirmed an “outperform” rating and set a $129.00 price target on shares of Addus HomeCare in a research note on Thursday, February 27th. JMP Securities assumed coverage on shares of Addus HomeCare in a research report on Monday, December 16th. They set an “outperform” rating and a $150.00 target price for the company. StockNews.com lowered shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Oppenheimer raised their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Finally, Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $132.78.

Addus HomeCare Stock Performance

ADUS stock traded down $1.33 during trading on Wednesday, reaching $93.39. 16,711 shares of the company were exchanged, compared to its average volume of 198,976. The stock’s 50 day moving average price is $117.30 and its 200 day moving average price is $124.04. Addus HomeCare has a 52-week low of $87.88 and a 52-week high of $136.72. The company has a market cap of $1.70 billion, a P/E ratio of 21.37, a PEG ratio of 1.41 and a beta of 0.97.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The firm had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. As a group, equities research analysts forecast that Addus HomeCare will post 4.59 EPS for the current year.

Insiders Place Their Bets

In other news, CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the sale, the chief executive officer now owns 79,397 shares in the company, valued at $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 4.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Addus HomeCare

Several institutional investors have recently added to or reduced their stakes in ADUS. Quarry LP acquired a new stake in Addus HomeCare in the 3rd quarter worth about $28,000. Natixis lifted its holdings in shares of Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company’s stock worth $31,000 after acquiring an additional 132 shares during the period. Smartleaf Asset Management LLC boosted its position in shares of Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock worth $35,000 after acquiring an additional 214 shares during the last quarter. Farther Finance Advisors LLC grew its holdings in Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after purchasing an additional 366 shares during the period. Finally, Parkside Financial Bank & Trust grew its holdings in Addus HomeCare by 38.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock valued at $67,000 after purchasing an additional 148 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.